Partner David Rosen was quoted in an article published in Business Insider on April 18, 2014, titled “Why America Needs This Dangerous New Painkiller.” The article discusses Zohydro, a new hydrocodone painkiller, and the sharp criticism it has drawn because of the potential for abuse since it does not yet have tamper-resistant technology that would make it more difficult to crush and snort. Rosen was quoted saying, “”With respect to having a product available for use for chronic pain, when the drug is used appropriately, yes, this is a good call.”
People
Related News
June 23, 2025
In the News
Thomas Ferrante Shares Insight on Compliance Considerations for Remote Patient Monitoring
June 20, 2025
In the News
Brian Wheeler and Lyman Thai Comment on Private Equity's Entry into Niche Sports
Foley & Lardner LLP partners Brian Wheeler and Lyman Thai described private equity's growing investments in niche sports in the Pensions & Investments article, "Ares Management buys minority stake in French sailing team."
June 17, 2025
In the News
JillAllison Opell and Jonathan Goeringer Author Article on Legal Risks of Insurance Referral Fees
Foley & Lardner LLP partners JillAllison Opell and Jonathan Goeringer authored the New York Law Journal article, "Is Your Referral Fee Just a Disguised Commission?"